Medical Amboss
Michigan Medicine 13th Annual Western Michigan Liver Round-Up 2024
Michigan Medicine 13th Annual Western Michigan Liver Round-Up 2024
we'll contact you for payment after receiving your order
Couldn't load pickup availability
Michigan Medicine 13th Annual Western Michigan Liver Round-Up 2024
Include: 8 videos + 1 pdf, size: 2.67 GB
Target Audience: family and general practitioners, gastroenterologists, internists
Information:
New information regarding the medical evaluation of steatotic liver disease, how to evaluate a patient with a liver mass, and the diagnosis and management of patients with alcohol liver disease will be reviewed. In addition, an update on the detection and management of minimal hepatic encephalopathy, GI bleeding
in patients with cirrhosis, and how we can collectively increase the organ donor supply in Michigan will be provided.
Following the course, the participants will understand and be able to implement:
■ Latest developments in the diagnosis and treatment of steatotic liver disease including the use of diet and exercise, resmetlrom, GLP-1 agonists and bariatric endoscopy
■ Recommended approach to evaluating a patient with a liver mass
■ Approach to the diagnosis and treatment of patients with alcoholic liver disease with an emphasis on outpatient management
■ How to diagnose and treat patients with covert and overt hepatic encephalopathy
■ Recommended management of upper GI bleeding in patients with cirrhosis
■ Current efforts and outcomes to expand the organ donor pool in Michigan including the use of DCD livers
Join this hybrid program in-person and virtually. New information regarding the medical evaluation of steatotic liver disease, how to evaluate a patient with a liver mass, and the diagnosis and management of patients with alcohol liver disease will be reviewed. In addition, an update on the detection and management of minimal hepatic encephalopathy, GI bleeding in patients with cirrhosis, and how we can collectively increase the organ donor supply in Michigan will be provided.
Learning Objectives
At the conclusion of this activity, learners will be able to:
-
- Identify the latest developments in the diagnosis and treatment of steatotic liver disease including the use of diet, exercise, resmetirom, GLP-1 agonists and bariatric endoscopy
- Know how to evaluate a patient with a liver mass
- Know who and when to use anticraving agents in patients with alcoholic liver disease
- Know how to assess and treat patients with covert and overt hepatic encephalopathy.
- Utilize recommended management of upper GI bleeding in patients with cirrhosis including use of vasoconstrictors, antibiotics, and endoscopy
- Understand current efforts to expand the organ donor pool in Michigan including the use of DCD livers
Target Audience
This course is directed to family and general practitioners, gastroenterologists, internists, nurses, and other primary care providers including nurse practitioners and physician assistants interested in expanding their knowledge of clinical hepatology
Topics:
-
- Agenda.pdf
- Detection and Treatment of Hepatic Encephalopathy.mp4
- Diagnosis and Management of Alcohol Liver Disease.mp4
- Evaluation of a Patient with a Liver Mass.mp4
- Expanding the Organ Donor Pool in Michigan.mp4
- Medical Management of GI Bleeding in Cirrhosis.mp4
- Medical Management of Steatotic Liver Disease.mp4
- Panel Question & Answers 1.mp4
- Panel Question & Answers 2.mp4
Share
